Literature DB >> 10993410

Distress attributed to negative symptoms in schizophrenia.

J P Selten1, D Wiersma, R J van den Bosch.   

Abstract

The purpose of the study was to examine (1) to which negative symptoms schizophrenia patients attribute distress and (2) whether clinical variables can predict the levels of reported distress. With the help of a research assistant, 86 hospitalized patients completed a self-rating scale for negative symptoms. The 21 items of the self-rating scale were taken from the Scale for the Assessment of Negative Symptoms (SANS). A psychiatrist rated the patients on a number of scales, including the SANS. When patients reported particular symptoms, they were asked whether those symptoms bothered or distressed them. Answers to this question were highly dependent on the type of symptom involved. Distress was most often attributed to symptoms in the subscale avolition-apathy. Patients were also asked how much they were bothered or distressed. Again, high levels of distress were most often attributed to items in the subscale avolition-apathy. A summary score was developed for the level of reported distress: the distress score. Regression analysis showed that distress scores were not associated with the observed severity of negative symptoms or with the level of psychiatric disability. High distress scores were best predicted by the combination of high scores for depression and high scores for insight into positive symptomatology. However, this model explained only a quarter of the variance in distress scores.

Entities:  

Mesh:

Year:  2000        PMID: 10993410     DOI: 10.1093/oxfordjournals.schbul.a033490

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  6 in total

Review 1.  The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems.

Authors:  Christine C Gispen-de Wied; Lucres M C Jansen
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

Authors:  Stephanie G Park; Katiah Llerena; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Schizophr Res       Date:  2012-01-21       Impact factor: 4.939

3.  Atrophy of basal ganglia nuclei and negative symptoms in temporal lobe epilepsy.

Authors:  Elizabeth K Geary; Michael Seidenberg; Bruce Hermann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

4.  Self-report of attenuated psychotic experiences in a college population.

Authors:  Rachel L Loewy; Jennifer K Johnson; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2007-04-24       Impact factor: 4.939

5.  Apathy and the processing of novelty in schizophrenia.

Authors:  Robert M Roth; Nancy S Koven; Jo Cara Pendergrass; Laura A Flashman; Thomas W McAllister; Andrew J Saykin
Journal:  Schizophr Res       Date:  2007-09-19       Impact factor: 4.939

Review 6.  Mirtazapine adjunct for people with schizophrenia.

Authors:  Luke A Perry; Dhruvesh Ramson; Suzanne Stricklin
Journal:  Cochrane Database Syst Rev       Date:  2018-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.